These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 15996945

  • 1. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
    Robak T, Blonski JZ, Kasznicki M, Góra-Tybor J, Dmoszyñska A, Skotñicki A.
    Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B, Brugiatelli M, Krc I, Losonczi H, Holowiecki J, Planinc-Peraica A, Kusec R, Morabito F, Iacopino P, Lutz D.
    Cancer; 1997 Jun 01; 79(11):2107-14. PubMed ID: 9179056
    [Abstract] [Full Text] [Related]

  • 4. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V, Molica S, Capalbo S, Pogliani E, Battista C, Broccia G, Montillo M, Cuneo A, Leoni P, Specchia G, Castoldi G.
    Haematologica; 2001 Nov 01; 86(11):1165-71. PubMed ID: 11694402
    [Abstract] [Full Text] [Related]

  • 5. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988 Nov 01; 30(5-6):449-52. PubMed ID: 2906118
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
    Kalinka-Warzocha E, Wajs J, Lech-Maranda E, Ceglarek B, Holowiecki J, Federowicz I, Walewski J, Czyz J, Robak T, Warzocha K, Polish Lymphoma Research Group.
    Cancer; 2008 Jul 15; 113(2):367-75. PubMed ID: 18470902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T.
    Ann Hematol; 2005 Feb 15; 84(2):63-70. PubMed ID: 15558283
    [Abstract] [Full Text] [Related]

  • 9. CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study.
    Hansen MM, Andersen E, Christensen BE, Christiansen I, Geisler C, Kristensen D, Jensen KB, Junker P.
    Nouv Rev Fr Hematol (1978); 1988 Feb 15; 30(5-6):433-6. PubMed ID: 3065739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.
    Montserrat E, Alcalá A, Alonso C, Besalduch J, Moraleda JM, García-Conde J, Gutierrez M, Gomis F, Garijo J, Guzmán MC.
    Nouv Rev Fr Hematol (1978); 1988 Feb 15; 30(5-6):429-32. PubMed ID: 3065738
    [Abstract] [Full Text] [Related]

  • 12. Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies.
    Laurencet FM, Zulian GB, Guetty-Alberto M, Iten PA, Betticher DC, Alberto P.
    Br J Cancer; 1999 Mar 15; 79(7-8):1215-9. PubMed ID: 10098762
    [Abstract] [Full Text] [Related]

  • 13. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group.
    Robak T, Blonski JZ, Wawrzyniak E, Gora-Tybor J, Palacz A, Dmoszynska A, Konopka L, Warzocha K, Jamroziak K.
    Cancer; 2009 Jan 01; 115(1):94-100. PubMed ID: 19025975
    [Abstract] [Full Text] [Related]

  • 14. Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
    Robak T, Błoński JZ, Kasznicki M.
    Leuk Lymphoma; 2001 May 01; 41(5-6):545-57. PubMed ID: 11378572
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
    Raphael B, Andersen JW, Silber R, Oken M, Moore D, Bennett J, Bonner H, Hahn R, Knospe WH, Mazza J.
    J Clin Oncol; 1991 May 01; 9(5):770-6. PubMed ID: 2016618
    [Abstract] [Full Text] [Related]

  • 17. [Chronic lymphatic leukemia. Peroral cladribine as primary treatment].
    Gjedde SB, Juliusson G, Hansen MM.
    Ugeskr Laeger; 1996 Nov 04; 158(45):6432-4. PubMed ID: 8992677
    [Abstract] [Full Text] [Related]

  • 18. [Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
    Koffi KG, Nanho DC, Tolo A, N'Dathz E, Kouakou B, Meite N, Ayemou R, Sanogo I.
    Bull Cancer; 2009 Sep 04; 96(9):901-6. PubMed ID: 19696007
    [Abstract] [Full Text] [Related]

  • 19. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL.
    Hematol Oncol; 1993 Sep 04; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract] [Full Text] [Related]

  • 20. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
    Ayyildiz O, Isikdogan A, Bolaman Z, Muftuoglu E.
    Saudi Med J; 2004 Dec 04; 25(12):2054-6. PubMed ID: 15711709
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.